Baseline characteristics across groups
| Symptomatic women n=1684 | Asymptomatic women n=102 | P value* | |
| Self-reported data | |||
| Age, years | 62.8 (9.6) | 60.9 (10.2) | 0.059† |
| Hypertension | 922 (55) | 17 (19) | <0.001 |
| DM I | 20 (1) | 0 (0) | 0.02 |
| DM II | 182 (11) | 3 (3) | |
| Smoking | 270 (16) | 13 (14) | 0.38 |
| Dyslipidaemia | 1042 (62) | 19 (21) | <0.001 |
| Family history | 882 (54) | 29 (32) | <0.001 |
| Cerebrovascular disease | 132 (8) | 1 (1) | 0.04 |
| Peripheral artery disease | 100 (6) | 4 (4) | 0.58 |
| Clinical assessments | |||
| Body mass index, kg/m2 | 27.1 (5.4) | 24.9 (3.5) | <0.001 |
| Heart rate, beats/min | 70.6 (10.9) | 69.4 (11.5) | 0.24 |
| Systolic BP, mm Hg | 131.3 (21.0) | 115.9 (17.0) | <0.001 |
| Diastolic BP, mm Hg | 70.4 (16.1) | 60.3 (8.2) | <0.001 |
| Total cholesterol, mmol/L | 5.0 (1.1) | 5.4 (0.9) | <0.001 |
| LDL, mmol/L | 2.8 (1.0) | 3.1 (0.8) | 0.004 |
| HDL, mmol/L | 1.6 (0.5) | 1.9 (0.5) | <0.001 |
| Triglycerides, mmol/L | 1.3 (0.7) | 1.0 (0.5) | <0.001 |
| HbA1c, non-diabetics, IFCC | 38.1 (4.7) | 37.4 (4.1) | 0.568 |
| Medication, n (%) | |||
| Acetyl salicylic acid | 675 (41) | 3 (3) | <0.001 |
| Beta-blocker | 469 (28) | 3 (3) | <0.001 |
| Calcium antagonist | 378 (23) | 7 (7) | 0.001 |
| ACE-I/ARB | 561 (34) | 11 (11) | <0.001 |
| Statin | 842 (51) | 9 (9) | <0.001 |
Values are mean (SD) or number (%) unless otherwise indicated.
*P values from age-adjusted linear or logistic regression analysis.
†P value unadjusted.
ACE-I, ACE inhibitor; ARB, angiotensin-II receptor blocker; BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.;